Mephobarbital Side Effects
Applies to mephobarbital: oral tablet
Nervous system
Nervous system side effects including primarily somnolence (1% to 3%) have been reported. Agitation, confusion, hyperkinesia, ataxia, CNS depression, nightmares, nervousness, psychiatric disturbance, hallucination, insomnia, anxiety, dizziness, and abnormal thinking have all been reported to occur in less than 1% of treated patients. Headache has been reported with chronic use.[Ref]
Respiratory
Respiratory side effects including hypoventilation and apnea have been reported to occur in less than 1% of treated patients.[Ref]
Cardiovascular
Cardiovascular side effects including bradycardia, hypotension, and syncope have been reported to occur in less than 1% of treated patients.[Ref]
Gastrointestinal
Gastrointestinal side effects including nausea, vomiting, and constipation have been reported to occur in less than 1% of treated patients.[Ref]
Hypersensitivity
Hypersensitivity side effects including angioedema, skin rashes, and exfoliative dermatitis have been reported to occur with chronic use in less than 1% of treated patients.[Ref]
General
General side effects including fever have been reported to occur with chronic use in less than 1% of treated patients.[Ref]
Hepatic
Hepatic side effects including liver damage have been reported to occur with chronic use in less than 1% of treated patients.[Ref]
Hematologic
Hematologic side effects including megaloblastic anemia have been reported to occur with chronic use in less than 1% of treated patients.[Ref]
References
1. "Product Information. Mebaral (mephobarbital)" Sanofi Winthrop Pharmaceuticals, New York, NY.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
More about mephobarbital
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- 4 Reviews – Add your own review/rating
- Drug class: barbiturate anticonvulsants